Results 251 to 260 of about 258,864 (309)
ABSTRACT Purpose This study aimed to assess the feasibility of QSM in the human kidney during free‐breathing using respiratory gating for motion compensation. Methods Renal imaging of 15 healthy volunteers was performed using an axial multi‐echo GRE sequence on a 3 T MRI scanner.
Matthias Deitermann +7 more
wiley +1 more source
Iron, ESA, and HIF-Inhibitors: Are There Other Opportunities to Improve Anemia of CKD? [PDF]
Bonomini M +4 more
europepmc +1 more source
ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou +6 more
wiley +1 more source
The updated global burden of chronic kidney disease: one death every 20 seconds. [PDF]
Ortiz A +5 more
europepmc +1 more source
Bell's Palsy in 11,255 Cases: Cardiometabolic Associations in a Population‐Based Healthcare Database
Abstract Objective To estimate Bell's palsy incidence and evaluate the prevalence and associations with diabetes and other cardiometabolic conditions. Study Design Population‐based cohort study. Setting Clalit Health Services, the largest healthcare provider organization in Israel (2005‐2022).
Tomer Boldes +5 more
wiley +1 more source
Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty. [PDF]
Velioğlu A.
europepmc +1 more source
MSC‐Exo derived from human umbilical cord (HucMSC‐Exo) downregulates INHBA expression, consequently modulating the PI3K/AKT signaling cascade. This regulation attenuates renal fibroblast activation and extracellular matrix deposition, thereby exerting a renoprotective effect against fibrosis.
Meiling Chen +11 more
wiley +1 more source
Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on transfusion and intravenous iron use in chronic kidney disease anemia: a systematic review and meta-analysis. [PDF]
Huang J +5 more
europepmc +1 more source
Hyperglycemia‐driven cytokine activation initiates a sustained inflammatory cascade in diabetic kidney disease, promoting cellular injury and fibrogenic signaling. Integrating cytokine‐based biomarkers with risk stratification enables precision therapeutics that target inflammation and fibrosis, ultimately aiming to halt progression from early renal ...
Emmanuel Ifeanyi Obeagu
wiley +1 more source

